Clinical risk factors for portopulmonary hypertension. - Wikidata - awgldk - TriplyDB

Clinical risk factors for portopulmonary hypertension.

Clinical risk factors for portopulmonary hypertension.

http://www.wikidata.org/entity/Q33670620

about

Transoesophageal echocardiography during liver transplantation Hepato-cardiac disorders Portopulmonary hypertension: an update Inflammatory cytokines in pulmonary hypertension Pulmonary vascular complications of liver disease Pulmonary Arterial Hypertension and the Sex Hormone Paradox.Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.Plasma levels of S100A4 in portopulmonary hypertension Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation.Pulmonary hypertension in patients with hepatic cirrhosis and portal hypertension. An echographic study.Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.Portopulmonary hypertension and hepatopulmonary syndrome.Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Portopulmonary hypertension Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man.Portopulmonary hypertension: challenges in diagnosis and management.Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.Pulmonary hypertension in women.An official American Thoracic Society Statement: pulmonary hypertension phenotypes Pulmonary complications in cirrhotic candidates for liver transplantation Pulmonary arterial hypertension: an unusual cause of portal hypertension.Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.Serotonin transporter polymorphisms in patients with portopulmonary hypertension.Pulmonary manifestations of liver diseases.Update in pulmonary hypertension 2008.Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.Review article: liver transplantation for the pulmonary disorders of portal hypertension.Pulmonary complications in chronic liver disease.Therapeutic options in pulmonary hepatic vascular diseases.Review article: the management of cirrhosis in women.Portopulmonary hypertension: an update.What's new in the treatment of portopulmonary hypertension?Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works.Predictors of Waitlist Mortality in Portopulmonary Hypertension.Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.Effect of Cocaine on Pulmonary Vascular Remodeling and Hemodynamics in Human Immunodeficiency Virus-Transgenic Rats.Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors.

P2860

Q26781485-7C89FA1E-8510-4EC3-B621-45ABD549DAF9 Q26997114-0AE31AA4-6E44-4ECE-B5E8-55F3ACFB6ED0 Q27000393-722BE099-D2C0-47E5-87D9-F1FEA3391EA2 Q27007510-3638C648-8B93-4C78-B4BE-D4AE0F70EBF1 Q27021918-48C87961-5A01-46D0-927D-B9E16F54A008 Q30241478-D8E38230-03F4-4D52-9964-D956EE84AD23 Q30277940-D3F044B8-74CF-4CC1-B74C-9D708B649726 Q30397068-4CD29083-FD70-4D46-AAD1-84AA2329D093 Q33642831-59E3B464-58CB-4076-A4C4-8B8FB248ECCC Q33661274-7855F80F-1BED-4D94-95EC-D4E16CF2B916 Q33693313-8AFA24B0-44C8-4E80-8CBC-4133BF93E17B Q33786374-FE173706-68FF-4213-A4CE-C5500E834AAE Q33845479-130C9F21-652C-4E24-A724-35EEDBB71D99 Q33956819-5542C981-035C-42BF-9187-F40E41012800 Q33965877-1194F4EF-E54F-4276-B000-356765945ACF Q34245617-24782494-D8E2-46F4-89D5-7C0D34B8482F Q34409046-00B5D5FA-281F-4D5A-AAB0-121079D8F2DF Q34524900-FE604A10-7AB8-448F-BCF5-8723A5C43E6D Q34795939-BF110F8A-EFCC-4E98-89EB-20FE08C08CAD Q34919733-203148AD-819F-4F51-95D1-653BDD4B7B59 Q35724569-B41C5406-88A5-46C8-9D03-F70BCC14152E Q36180004-5342B2F5-5282-449F-87D4-0DA2299F84F6 Q37175244-F7C653CB-7489-46D5-A939-A2E41E2C7112 Q37277711-DB6E9337-6840-4025-AD32-1F300A171917 Q37428317-DC398152-C8EE-4EB7-9BAC-2A7244BDF88A Q37436774-F453937A-55C4-4AB7-B2BA-4637F9C9B981 Q37555387-F5D6759D-AD63-4ED1-8D33-1EA7FA61A26B Q37671277-89FFAEC1-4E78-4828-AA60-630024B11BD9 Q38059261-4620CE72-C0B4-40B8-9A85-8F255722C787 Q38148735-6695660A-A901-4608-9394-4B4481FB3C37 Q38168941-D1462A06-6470-4AB3-A74E-C1FBBD7E797D Q38255043-CC205FB8-5E65-4F5E-BFB1-34E57B0E0D99 Q38293632-17E02EB7-A023-49A9-9A4E-6B7D9B221D02 Q38424573-7ABA80EA-3891-4A61-A7EC-2B424E8C4905 Q38813349-A1FF2374-3BEC-4079-B3DB-E22F4B531592 Q39408329-8BE477B2-3061-4A37-8D68-D87BBCCB15B2 Q40332749-6D8A6CEA-79B6-4CB1-98C3-69266BB493DB Q40591652-8501810C-9ADF-4836-B044-64174B11DF8F Q40945385-C6BD9C9C-76DF-407C-A43C-FA1A33C95322 Q42133119-3B4F5FE8-2486-4375-97B8-82B24915173C

P2860

Clinical risk factors for portopulmonary hypertension.

http://www.wikidata.org/entity/Q33670620

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Clinical risk factors for portopulmonary hypertension.

@ast

Clinical risk factors for portopulmonary hypertension.

@en

type

label

Clinical risk factors for portopulmonary hypertension.

@ast

Clinical risk factors for portopulmonary hypertension.

@en

prefLabel

Clinical risk factors for portopulmonary hypertension.

@ast

Clinical risk factors for portopulmonary hypertension.

@en

P1433

Q33670620-31611A88-60B2-4754-9973-90AE6B30E1DC

P1476

Q33670620-A2B4C4E7-BE07-40ED-AB3F-389A41F46DA7

P2093

Q33670620-0E0DABD4-1BB8-40F1-8FEB-121300FCA07C

Q33670620-178BD0B5-3708-469B-935B-1D2ACEAFBF5F

Q33670620-34588770-7AE3-4F46-804A-8DD89B052C47

Q33670620-357CF79F-F551-4946-A251-22CD41ED07A5

Q33670620-501DB297-40AA-4158-8B34-C156A6C7B879

Q33670620-723C1C44-D904-4355-A6A2-C5FF12081100

Q33670620-88695DDD-ADF1-46C0-9DF4-5025F067BB0D

Q33670620-90BA626A-9CFC-47AF-AF12-7D1E744713B4

Q33670620-988844FA-54DB-45A2-ABA4-55BF514BACDC

Q33670620-9DDFBB1B-BBF1-4533-A31D-C3A45049672E

P2860

Q33670620-03EE391D-96CE-40C5-9E59-163EF2913566

Q33670620-2D279A86-4300-44D4-9D7B-FC9E515F74D6

Q33670620-2DDBE1DD-9895-446C-8A08-02ACFA0F474E

Q33670620-57A382D8-2A43-4522-AC76-D2AE7E747DA5

Q33670620-5A336123-5BA2-4600-93BF-BD957C8D17FA

Q33670620-5F584C81-3A3A-4BD4-B7C2-78D5A32F21B2

Q33670620-69B21C84-9CA1-4F58-914B-2B413CE3A9FB

Q33670620-6DF4B8FA-3A4C-4B25-8DCE-EE42F8FE8C97

Q33670620-74E8EACA-B13B-4486-91AF-82E6D72489BE

Q33670620-8580E1B6-978B-4460-9EFE-3E83A3C63C22

P304

Q33670620-72A84092-6C9E-4F7C-9548-535EFFD39AEF

P31

Q33670620-DEBA1F48-BAFC-402B-9DA5-628BAF0516B6

P356

Q33670620-36F28B2D-1C14-43B7-89AF-C37462897E90

P407

Q33670620-2593C268-223F-43A0-94EC-47801D234673

P433

Q33670620-FBC6113B-7B62-4B1A-876A-CBA744513852

P478

Q33670620-29888667-4F08-4BE2-818F-05E04C472123

P50

Q33670620-F31E0BCB-A276-435A-AAC7-93EFF7326B32

P577

Q33670620-B1F18E99-C03D-408D-B751-3781B4B7CF0F

P5875

Q33670620-BEFE695A-BE13-4ED0-A3AF-7AF142DB43EA

P698

Q33670620-673B1A35-A1CA-40CD-BAFF-4E0ED20F4F89

P932

Q33670620-7AD49F0A-A9C7-425F-BE1E-F75A5B387603

P356

P1433

P1476

Clinical risk factors for portopulmonary hypertension.

@en

P2093

David B Badesch

http://www.w3.org/2001/XMLSchema#string

Evelyn M Horn

http://www.w3.org/2001/XMLSchema#string

James F Trotter

http://www.w3.org/2001/XMLSchema#string

Kari E Roberts

http://www.w3.org/2001/XMLSchema#string

Michael B Fallon

http://www.w3.org/2001/XMLSchema#string

Michael J Krowka

http://www.w3.org/2001/XMLSchema#string

Neil Kaplowitz

http://www.w3.org/2001/XMLSchema#string

Pulmonary Vascular Complications of Liver Disease Study Group

http://www.w3.org/2001/XMLSchema#string

Raymond L Benza

http://www.w3.org/2001/XMLSchema#string

Robert S Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

A model to predict survival in patients with end-stage liver disease

Pulmonary arterial hypertension in France: results from a national registry.

Lung volumes in healthy nonsmoking adults.

Standardized single breath normal values for carbon monoxide diffusing capacity.

Pulmonary vascular abnormalities in cirrhosis.

Hemodynamics and survival of patients with portopulmonary hypertension.

High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension.

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

New predictors of outcome in idiopathic pulmonary arterial hypertension.

P304

196-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22275

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Darren B Taichman

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5318707

http://www.w3.org/2001/XMLSchema#string

P698

18537192

http://www.w3.org/2001/XMLSchema#string

P932

2824885

http://www.w3.org/2001/XMLSchema#string